Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiko Mitamura

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Journal of Clinical Microbiology|March 6, 2009
Oseltamivir-resistant influenza a viruses circulating in JapanDaisuke Tamura, Keiko Mitamura, Masahiko Yamazaki, et al.
Japanese Journal of Radiology|April 9, 2022
Newly developed artificial intelligence algorithm for COVID-19 pneumonia: utility of quantitative CT texture analysis for prediction of favipiravir treatment effectYoshiharu Ohno, Kota Aoyagi, Kazumasa Arakita, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 28, 2016
Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, JapanNorio Sugaya, Masayoshi Shinjoh, Chiharu Kawakami, et al.
Vaccine|April 22, 2022
Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 eraMasayoshi Shinjoh, Munehiro Furuichi, Hisato Kobayashi, et al.
Vaccine|June 13, 2019
Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013-18Masayoshi Shinjoh, Norio Sugaya, Munehiro Furuichi, et al.
Emerging Infectious Diseases|October 5, 2022
Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022Seiya Yamayoshi, Kiyoko Iwatsuki-Horimoto, Moe Okuda, et al.
Plos One|August 29, 2015
Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test ResultsMasayoshi Shinjoh, Norio Sugaya, Yoshio Yamaguchi, et al.
Plos One|March 26, 2021
Influenza vaccine effectiveness against influenza A in children based on the results of various rapid influenza tests in the 2018/19 seasonMasayoshi Shinjoh, Norio Sugaya, Yoshio Yamaguchi, et al.
Science Translational Medicine|May 17, 2022
Characterization of the SARS-CoV-2 B.1.621 (Mu) variantPeter J Halfmann, Makoto Kuroda, Tammy Armbrust, et al.
Eclinicalmedicine|February 16, 2021
Antibody titers against SARS-CoV-2 decline, but do not disappear for several monthsSeiya Yamayoshi, Atsuhiro Yasuhara, Mutsumi Ito, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Clinical Microbiology|March 6, 2009
Oseltamivir-resistant influenza a viruses circulating in JapanDaisuke Tamura, Keiko Mitamura, Masahiko Yamazaki, et al.
Japanese Journal of Radiology|April 9, 2022
Newly developed artificial intelligence algorithm for COVID-19 pneumonia: utility of quantitative CT texture analysis for prediction of favipiravir treatment effectYoshiharu Ohno, Kota Aoyagi, Kazumasa Arakita, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 28, 2016
Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, JapanNorio Sugaya, Masayoshi Shinjoh, Chiharu Kawakami, et al.
Vaccine|April 22, 2022
Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 eraMasayoshi Shinjoh, Munehiro Furuichi, Hisato Kobayashi, et al.
Vaccine|June 13, 2019
Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013-18Masayoshi Shinjoh, Norio Sugaya, Munehiro Furuichi, et al.
Emerging Infectious Diseases|October 5, 2022
Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022Seiya Yamayoshi, Kiyoko Iwatsuki-Horimoto, Moe Okuda, et al.
Plos One|August 29, 2015
Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test ResultsMasayoshi Shinjoh, Norio Sugaya, Yoshio Yamaguchi, et al.
Plos One|March 26, 2021
Influenza vaccine effectiveness against influenza A in children based on the results of various rapid influenza tests in the 2018/19 seasonMasayoshi Shinjoh, Norio Sugaya, Yoshio Yamaguchi, et al.
Science Translational Medicine|May 17, 2022
Characterization of the SARS-CoV-2 B.1.621 (Mu) variantPeter J Halfmann, Makoto Kuroda, Tammy Armbrust, et al.
Eclinicalmedicine|February 16, 2021
Antibody titers against SARS-CoV-2 decline, but do not disappear for several monthsSeiya Yamayoshi, Atsuhiro Yasuhara, Mutsumi Ito, et al.
Pageof 6